Comprehensive End-to-End Data Quality System Established by WuXi AppTec DMPK

How Does Precision Source Control Assure Our DMPK Data Quality?

From Laboratory Animals to Biological Samples

Drug Metabolism and Pharmacokinetics (DMPK) studies serve as the navigator and guardian of safety throughout the drug discovery and development process. They not only identify and screen the pharmacokinetic properties of candidate compounds but also provide guidance for optimizing molecular structures and designing clinical trials. DMPK research determines if a drug can reach its target and be effective by studying its exposure, distribution, metabolism, and elimination. It also assesses safety, focusing on off-target side effects and distribution-related risks. All these aspects rely on a fundamental element: stringent quality control. At the starting point of this research chain are laboratory animals and biological samples. This blog explains the significance of source control in DMPK studies and how adopting an end-to-end approach in managing laboratory animals and biological samples helps maintain data quality and drive project progression.

Why Laboratory Animal Management Matters

In high-throughput screening studies, speed is crucial, but quality is fundamental. Uncontrolled variability in animal health or genetics can introduce noise or bias that invalidates study outcomes. Strict quality control of animal resources can significantly increase the success rate of these studies.

Our approach includes:

• Strict animal source control: Implementation of comprehensive vendor qualification, selection standards, and third-party verification ensures consistent and reliable animal sources.

• Multi-species coverage: More than ten species are covered, including non-human primates (NHPs), pigs, rabbits, dogs, rats, mice, cats, and so on. To properly meet a variety of research demands, we also offer specialized models such as nude, SCID (Severe Combined Immunodeficiency Model), transgenic, knockout, and humanized mice.

• Rapid study kick-off: We offer "no lead time" for PK study initiation by utilizing extensive resource reserves and robust scheduling capabilities, guaranteeing data continuity and efficient project advancement.

Stable Environment Control

Environment and Clinical Pathology: Stability Builds Confidence

Stability is the foundation of quality. Professional clinical pathology testing enables early risk detection and timely mitigation.

Controlled, Stable Environment

Our facilities are designed to minimize environmental variables. Functional areas are clearly segregated, and personnel, animals, lab supplies, and waste follow unidirectional flow paths to prevent cross-contamination. Intelligent electronic systems provide 24/7 real-time monitoring of temperature, humidity, ventilation, air filtration, contamination, and pressure differentials, ensuring a stable environment that supports consistent animal metabolic function.

Clinical Pathology Testing

Ethics first: All studies are conducted under rigorous ethical review and full-process oversight and are supported by AAALAC International accreditation.

Dynamic monitoring: An independent clinical pathology laboratory supports multi-parameter testing (e.g., hematology and clinical chemistry), and routine third-party assessments (such as quarterly water quality testing, feed testing, and other checks) help ensure that animal health status remains continuously visible and fully traceable throughout the study.

Quality assurance: We adhere to stringent industry standards for non-human primates (NHPs) to ensure optimal animal health and enhance study reliability.

Specialized Veterinary Team for Preclinical DMPK Studies

Lifecycle Management: The Digital Management Loop from Animals to Biological Samples

In DMPK studies, data integrity depends on meticulous implementation. To eliminate manual tracking errors, we have implemented an intelligent, end-to-end management system that creates a digital safety net covering the entire lifecycle from animals to biological samples.

Comprehensive Animal Management

High-quality biological samples begin with high-quality animal care. Our digital infrastructure supports the core of DMPK studies:

• Veterinary oversight: A dedicated veterinary team provides continuous clinical care and health monitoring across the full study lifecycle, from animal enrollment and study conduct through to study close‑out and archiving.

• Digital identity: Microchips and electronic cage cards integrated with the Resource Management System (RMS) ensure unambiguous individual animal identification and synchronized records across systems.

• Intelligent scheduling: Automated scheduling engines assign and track dosing, sampling, and husbandry tasks, reducing the risk of missed doses or missed sample collections.

• Closed-loop digital workflow: A tightly controlled digital workflow, enrollment → husbandry → study procedures → archiving, enforces full chain‑of‑custody and prevents any unrecorded movement or use of animals.

• Electronic records and traceability: All health observations, dosing logs, and study data are captured in a fully integrated electronic system, creating an auditable, permanently retrievable individual animal history.

End-to-End Digital Management System

Precision Biological Sample Management

The transfer of biological samples from the animal facility to the bioanalytical laboratory presents potential management risks; we have implemented a comprehensive error-prevention system to ensure secure handling, traceability, and chain-of-custody.

• Automation first: Label printing, automated blood sampling (ABS), and plasma separation are prioritized for automation to minimize pre-analytical variability and human error.

• One tube, one code: Every collection tube is assigned a unique barcode ID linked to the RMS for real-time, end-to-end traceability.

• Dedicated sample management: An independent sample management team acts as the operational interface between the animal facility and analytical laboratories, ensuring secure, seamless transport and handover.

• Double verification: By combining auto-capping machines with personal digital assistant (PDA) scanning and electronic ledgers, we effectively eliminate "fat finger" errors to prevent sample misidentification or loss.

• Electronic monitoring: From receipt and chain-of-custody to temperature-controlled storage, every operation is logged in the electronic management system, ensuring that sample history is fully auditable.

Together, these controls reduce pre-analytical risk, protect sample integrity, and strengthen the quality of downstream DMPK data.

Automated Workflow for Enhanced Efficiency

The Bottom Line

Quality is the Lifeline of Drug Discovery and Development

WuXi AppTec DMPK protects every detail from animals to biological samples through end-to-end process controls, RMS-enabled digital traceability, and adherence to industry-leading standards such as AAALAC International accreditation. We are committed to ensuring the authenticity, completeness, and traceability of every data point, and to being your most trusted R&D partner.

Authors: Lihua Qiao, Jacob Zhi Chen, Shuyun Zhou

Talk to a WuXi AppTec expert today to get the support you need to achieve your drug development goals.

Committed to accelerating drug discovery and development, we offer a full range of discovery screening, preclinical development, clinical drug metabolism, and pharmacokinetic (DMPK) platforms and services. With research facilities in the United States (New Jersey) and China (Shanghai, Suzhou, Nanjing, and Nantong), 1,000+ scientists, and over fifteen years of experience in Investigational New Drug (IND) application, our DMPK team at WuXi AppTec are serving 1,600+ global clients, and have successfully supported 1,800+ IND applications.